Texas Oncology-Grapevine — Grapevine, Texas

Texas Oncology-Grapevine is a clinical research site located in Grapevine, Texas, United States.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Texas Oncology-Grapevine has participated in 8 clinical trials with 3 currently active.

Therapeutic areas: Tumors, Stage II Breast Cancer, Stage IIIA Breast Cancer.

Sponsors: Eisai Inc., Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology-Grapevine?

Texas Oncology-Grapevine has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology-Grapevine conducted?

Texas Oncology-Grapevine has 8 clinical trials on record, with 3 currently active. Their work covers Tumors, Stage II Breast Cancer, Stage IIIA Breast Cancer.

Is Texas Oncology-Grapevine accredited by Crixeo Health?

Yes — Texas Oncology-Grapevine holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Texas Oncology-Grapevine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.